logo inserm ifrb fondateurCC logoUSPN

Publications of INSERM UMR 1125

Former publication of present members of Li2P

Elodie Rivière

  • Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren’s syndrome. E Rivière, J Pascaud, A Virone et al, Arthritis Rheumatol. 2021 ; 3(4):631-640
  • Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. E Rivière, J Pascaud, N Tchitchek, et al., , Ann Rheum Dis. 2020 ; 79:1468-1477
  • Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. E Rivière1, J Sellam1, A Courties, et al., , Arthritis Res Ther. 2016 ; 18(1):294. 1equal contributors
  • Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study. E Rivière, F Cohen Aubart, T Maisonobe, et al., Journal of Neurology, 2017;264(6):1218-1226
  • Restoration of default blood monocyte-derived macrophage polarization with adalimumab but not etanercept in rheumatoid arthritis. A Paoletti, B Ly, S Bitoun, G Nocturne, E Rivière, et al., Frontiers in Immunology, 2022 ; 23;13:832117
  • Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome. Dupré A, Pascaud J, Rivière E, et al., RMD Open. 2021; 7(1):e001442
  • Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors. A Paoletti, J Rohmer, B Ly, J Pascaud, E Rivière, R Seror, B Le Goff, G Nocturne, X Mariette, J Immunol, 2019 ; 1;203(7):1766-1775
  • Role of the IL-12/IL-35 balance in patients with Sjögren syndrome. Fogel O, Rivière E, Seror R, et al.,. J Allergy Clin Immunol. 2018 ; 142(1):258-268.e5

Jérome Biton

  • Tertiary lymphoid structure-B cells narrow regulatory T cells impact in lung cancer patients. C. Germain, P. Devi-Marulkar, S. Knockaert, J. Biton, H. Kaplon, L. Letaïef, J. Goc, A Seguin-Givelet, D. Gossot, N. Girard, P. Validire, M. Lefevre, D. Damotte, M. Alifano, F. Lemoine, K. Steele, J-L. Teillaud, S. A. Hammond and MC. Dieu-Nosjean. Frontiers in Immunology. 2021 Mar 8;12:62677
  • Proposal for a combined histo-molecular algorithm to distinguish multiple primary adenocarcinomas from intrapulmonary metastasis in patients with multiple lung tumors. A. Mansuet-Lupo, M. Barritault, M. Alifano, A Janet-Vendroux, M. Zarmaev, J. Biton, Y. Velut, C. Le Hay, I. Cremer2, J-F Régnard, L. Fournel, B. Rance, M. Wislez, P. Laurent-Puig, R. Herbst, D. Damotte, H. Blons.Journal of Thoracic Oncology. 2019 May;14(5):844-856.
  • The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. D. Damotte, S.Warren, J. Arrondeau, P. Boudou-Rouquette, A. Lupo, J. Biton, H. Ouakrim, M. Alifano, C. Gervais, A, Bellesoeur, N. Kramkimel, C. Tlemsani, B. Burroni, A. Duche, F. Letourneur, H. Si, R. Halpin, T. Creasy, R. Herbst, X. Ren, P. Morel, A. Cesano, F. Goldwasser, K. Leroy. Journal of Translational Medicine.  2019 Nov 4;17(1):357.
  • Proposal for a combined histo-molecular algorithm to distinguish multiple primary adenocarcinomas from intrapulmonary metastasis in patients with multiple lung tumors. A. Mansuet-Lupo, M. Barritault, M. Alifano, A Janet-Vendroux, M. Zarmaev, J. Biton, Y. Velut, C. Le Hay, I. Cremer2, J-FThe tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. D. Damotte, S.Warren, J. Arrondeau, P. Boudou-Rouquette, A. Lupo, J. Biton, H. Ouakrim, M. Alifano, C. Gervais, A, Bellesoeur, N. Kramkimel, C. Tlemsani, B. Burroni, A. Duche, F. Letourneur, H. Si, R. Halpin, T. Creasy, R. Herbst, X. Ren, P. Morel, A. Cesano, F. Goldwasser, K. Leroy. Journal of Translational Medicine.  2019 Nov 4;17(1):357.

 

 

Patrice Decker

  • Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Lindau D, Rönnefarth V, Erbacher A, Rammensee HG, Decker P. Eur J Immunol, 2011, 41:669-81.
  • Antineuronal antibodies in sporadic late-onset cerebellar ataxia. Bürk K, Wick M, Roth G, Decker P, Voltz, R.  J Neurol, 2010, 257:59-62.
  • Neurological symptoms in patients with biopsy proven celiac disease. Bürk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, Rammensee HG, Oertel WHO. Mov Disord, 2009, 24:2358-62.
  • Neutrophils, dendritic cells and chromatin-mediated pathogenesis in systemic lupus erythematosus. Lindau D, Decker P.  Autoimmunity, 2009, 42:254-6.
  • Chromatin modifications, oxidative stress and nucleosome autoantibodies. In: The epigenetics of autoimmune diseases. Erbacher A, Decker P.  2009, 119-34. Editor, Moncef Zouali; Publisher, Wiley Inc., New York.
  • Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. Kloss M*, Decker P*, Baltz K, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih H.  J Immunol, 2008, 181: 6711-19. *The first two authors contributed equally to this work.
  • The PDE4 inhibitor rolipram prevents NF-kappaB binding activity and proinflammatory cytokine release in human chorionic cells. Hervé R, Schmitz T, Evain-Brion D, Cabrol D, Leroy MJ, Méhats C. J Immunol. 2008 Aug 1;181(3):2196-202.
  • Circulating nucleosomes due to a defective clearance of dying cells: consequences in systemic lupus erythematosus. Erbacher A, Rönnefarth V, Decker P.  Autoimmunity, 2007, 40:311-14.
  • Heteroclitic properties of mixed a- and aza-b3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome. Dali H, Busnel O, Hoebeke J, Bi L, Decker P, Briand JP, Baudy-Floc’h M, Muller S.  Mol Immunol, 2007, 44:3024-36.
  • TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. Rönnefarth V, Erbacher A, Lamkemeyer T, Madlung J, Nordheim A, Rammensee HG, Decker P. J Immunol, 2006, 177:7740-9.
  • Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Decker P, Kötter I, Klein R, Berner B, Rammensee HG.  Rheumatology, 2006, 45:1087-95.
  • Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. Decker P, Singh-Jasuja H, Haager S, Kötter I, Rammensee HG.  J Immunol, 2005, 174:3326-34.
  • Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectromotry. Dengjel J*, Decker P*, Schoor O, Altenberend F, Weinschenk T, Rammensee HG, Stevanovic S. Eur J Immunol, 2004, 34:3644-51. *The first two authors contributed equally to this work.
  • Nucleosomes induce lymphocyte necrosis. Decker P, Wolburg H, Rammensee HG.  Eur J Immunol, 2003, 33:1978-87.
  • Detection of nucleosome particles in the sera of patients with SLE using monoclonal antibody 4H7. Williams RC, Malone CC, Meyers C, Decker P, Muller S.  J Rheumatol, 2001, 28:81-94.
  • Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. Decker P, Isenberg DA, Muller S.  J Biol Chem, 2000, 275:9043-6.
  • Molecular and structural properties of three autoimmune IgG monoclonal antibodies to histone H2B. Monestier M, Decker P, Briand JP, Gabriel JL, Muller S.  J Biol Chem, 2000, 275:13558-63.
  • Identification of a minimal T cell epitope recognised by anti-nucleosome Th cells in the C-terminal region of histone H4. Decker P, Le Moal A, Briand JP, Muller S.  J Immunol, 2000, 165:654-62.

USPN Campus de Bobigny

tour illustration bobigny

web li2p V3

-->